Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / GENOMIC REV ETF
-
Total 13F shares
-
2,944,101
-
Share change
-
+373,340
-
Total reported value
-
$101,464,963
-
Price per share
-
$34.47
-
Number of holders
-
65
-
Value change
-
+$13,071,408
-
Number of buys
-
46
-
Number of sells
-
18
Institutional Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q2 2019
As of 30 Jun 2019,
ARK ETF TR - GENOMIC REV ETF (ARKG) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,944,101 shares.
The largest 10 holders included
MORGAN STANLEY, Carroll Financial Associates, Inc., UBS Group AG, LPL Financial LLC, COMMONWEALTH EQUITY SERVICES, LLC, Cetera Advisor Networks LLC, Snowden Capital Advisors LLC, Cambridge Investment Research Advisors, Inc., STEPHENS INC /AR/, and RAYMOND JAMES & ASSOCIATES.
This page lists
66
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.